Pro UKPro AUPro CA Pro HK FULLER TREACY MONEY StockTube Mining Capital Oil Capital Tech Capital Biotech Capital CN
Sign up USA
Hutchison China MediTech Limited (LON:HCM)

Hutchison China MediTech Limited (LON:HCM)

Share Price
4,515.00 p
Change
-1085 (-19.38 %)
Market Cap
£3,007.83 m
Proactive Investors - Run By Investors For Investors

Hutchison China MediTech Limited

Chi-Med is a China-based healthcare group that researches, develops, manufactures & sells pharmaceuticals and health-related consumer products.

Hutchison China MediTech is traded in the ISDX Exchange HERE

EPIC: HCM
Market: AIM:HCM
NASDAQ:HCM
52-week High/Low: 5,920.00p / 3,877.00p
Sector: Health Care, Equipment & Services
Market Cap: 3,007.83M
Website: www.chi-med.com

Hutchison China MediTech Limited

www.chi-med.com

Interactive graph

col 3
col 4
col 5
col 6

Hutchison China MediTech Limited Timeline

Article
Fri
Hutchison Chi-Med sheds £900mln as lung cancer trial disappoints
RNS
Thu
Phase III FALUCA Trial Results for Fruquintinib
RNS
October 30 2018
Total Voting Rights
RNS
October 21 2018
Grant of Share Options under Share Option Scheme
RNS
October 17 2018
Chi-Med Initiates a Ph I Trial of HMPL-523 for AML
RNS
October 04 2018
Appointment of HSBC Bank plc as Broker in London
Newswire
September 05 2018
Hutchison ChinaMediTech's colorectal cancer treatment approved in China
RNS
September 04 2018
Fruquintinib Approved for CRC in China
RNS
August 30 2018
Total Voting Rights
RNS
August 06 2018
Grant of Share Options under Share Option Scheme
Newswire
July 27 2018
Hutchison Chi-Med expects first drug launch by year end
RNS
July 26 2018
2018 Interim Results and Clinical Programs Update
Newswire
July 23 2018
Hutchison China Meditech starts US proof-of-concept trial for key cancer drug
RNS
July 22 2018
Start of Sulfatinib US Phase Ib/II PoC trial
Article
March 12 2018
Hutchison China Meditech looks to first drug approval this year
Newswire
March 13 2017
Hutchison China MediaTech reports record 2016 revenue as commercial sales rise
Newswire
February 14 2017
Hutchison China MediTech kicks off first human trial for potential new cancer drug
Newswire
August 02 2016
Hutchison China MediTech half year charts big progress
Newswire
May 13 2016
Hutchison China MediTech enrols patients for Phase III testing
Newswire
April 12 2016
Hutchison China Meditech starts trials of blood cancer drug
View All StoriesView all RNS

Columns Including HCM

- Hybridan Small Cap Wrap
Small Cap Wrap - Golden Saint Technologies Ltd; Greenfields Petroleum; Adept4 ; Good Energy and more...
- Stockpot
Fevertree Drinks joins "Mindless Momentum" portfolio just as it shows signs of losing some fizz
- Stockpot
Momentum investing: Use the Force, Luke
- Hybridan Breakfast News
Breakfast News - Baron Oil, CAP-XX, Osirium Technologies and more...
- Beaufort Securities
Beaufort Securities Breakfast Alert : Galileo Resources and Hutchison China Meditech
VIEW ALL

Market Reports Including HCM

- Ftse & Small Cap Market Report
FTSE 100 closes higher, boosted by earnings and weaker pound
- Market Preview
BT investors 'flying blind' as it reports first quarter results without net adds
- Market Preview
Apres moi le deluge: Flood of blue chip results to dominate in coming week, including BT Group
- Ftse & Small Cap Market Report
FTSE 100 can’t hold gains and closes in red as sterling firms
- Market Preview
Chancellor's Spring Statement unlikely to include big spending plans, says think-tank
VIEW ALL
Partners:
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use